Lipella Pharmaceuticals Inc.

LIPO

Industry: Pharmaceutical Preparations
SEC CIK: 0001347242

SEC filings (opens in a new tab)

No open-market purchases or sales by Lipella Pharmaceuticals Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding Lipella Pharmaceuticals Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023 All holders in Q4 2022

13F holders of LIPO: Q4 2022 compared with Q1 2023
Measure	Q4 2022	Q1 2023	Change
Holders	2	6	+4
Shares	14.1K	53.3K	+39.2K (+278.4%)
Value	$44.7K	$103.6K	+$58.9K (+131.7%)

New holders (5)

Institutions that held Lipella Pharmaceuticals Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to LIPO in Q1 2023
Institution	Shares	Value	% of portfolio
Vanguard Group Inc	37,074	$72.3K	0.00%
Two Sigma Securities, LLC	13,137	$25.6K	0.00%
Tower Research Capital LLC (TRC)	2,218	$4.00K	0.00%
FMR LLC	52	$100	0.00%
Wells Fargo & Company	8	$16	0.00%

Sold out (1)

Institutions that held Lipella Pharmaceuticals Inc. at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of LIPO in Q1 2023
Institution	Shares, Q4 2022	Value, Q4 2022
Citadel Advisors LLC	12,508	$39.8K